Explore the detailed record of transactions filed by Cohen Neil Harris, Director. Director active across 1 companies, notably Chemomab Therapeutics Ltd.. In total, 4 reports have been recorded. Total volume traded: €40k. The latest transaction was disclosed on 18 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Neil Harris Cohen is a Director of Chemomab Therapeutics Ltd. In this role, he participates in the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is an asset for the organization.